Kenzi RIBOULET-ZEMOULI
Independent, interdisciplinary drug policy researcher, committed with human rights, ethics, and sustainability.
Based in Barcelona, Spain.
Co-founder of non-profits FAAAT, NORML France, IMCPC & CATNPUD.
ORCID id: 0000-0003-2761-1533
Policies of the 21st century for controlled substances.
SOUND DRUG POLICIES =
Resilient planet +
Sustainable societies.
Independent research benefits us all, but it needs support!
Help me continuing needed studies, become a patron on www.patreon.com/teluobir Visit patreon, support my researchMAIN PUBLICATIONS
2020
2019
2018
La dépénalisation, c’est pour quand ? (ASUD à l’ONU)
ASUD Journal nº63, décembre 2020. Page 31, dans le dossier "International : ASUD à l’ONU, des nouvelles du front"
‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology
Drug Science Policy and Law 6:1–37. DOI: 10.1177/2050324520945797
Votación de la ONU sobre el CBD: viendo a través de una cortina de humo de confusión
Blog de la Fundación CANNA
U.N. vote on CBD: seeing through the smokescreen of confusions
Blog of Fundación CANNA
Interview de Bernard Leroy, le membre français de l’OICS
Transcript of the interview.
Le CBD, entre victoire et panique : arrêt Kanavape et vote aux Nations Unies
Cannabis médicinal : l’Algérie, parmi les “anti-science” à l’ONU ?
Blog de Médiapart.
ONU: la France prend la défense du cannabis thérapeutique
Cannabis y farmacopeas (2/2) ¿Qué monografías son necesarias en una farmacopea cannábica?
Publicado en el marco del III congreso CANNABMED, Barcelona, España
Cannabis y farmacopeas (1/2) Pasado, presente y futuro
Publicado en el marco del III congreso CANNABMED, Barcelona, España
CBD as a ‘narcotic’? Food for thought
ISBN: 979-10-97087-77-7
![[Fact sheet CND63 – Changes in the scope of control over cannabis] Clarifying the recommendation on CBD products](https://i2.wp.com/kenzi.zemou.li/wp-content/uploads/2020/03/IMG_9242-scaled.jpg?resize=400%2C250&ssl=1)
[Fact sheet CND63 – Changes in the scope of control over cannabis] Clarifying the recommendation on CBD products
![[Fact sheet CND63 – Changes in the scope of control over cannabis] Clarifying the evidence behind the recommendations.](https://i0.wp.com/kenzi.zemou.li/wp-content/uploads/2020/03/datafactsheet-cover.png?resize=400%2C250&ssl=1)
[Fact sheet CND63 – Changes in the scope of control over cannabis] Clarifying the evidence behind the recommendations.
![[Fact sheet CND63 – Changes in the scope of control over cannabis] Traditional medicine, Cannabis & the 1961 Convention](https://i1.wp.com/kenzi.zemou.li/wp-content/uploads/2020/03/TMfactsheet-cover.png?resize=400%2C250&ssl=1)
[Fact sheet CND63 – Changes in the scope of control over cannabis] Traditional medicine, Cannabis & the 1961 Convention
Cannabis à l’ONU : un outil pour suivre la position de chaque pays
Cannabis Scheduling & EU common position – Elements Document (February 2020)
DOI: 10.13140/RG.2.2.31659.18724
ONU : entre inertie politique et conservatisme, le cannabis en ballottage défavorable
Scope and definition of the exemption covering “hemp” in the international drug control Conventions. A total exemption – by purpose
DOI: 10.13140/RG.2.2.15697.28008
Dossier OMS y cannabis medicinal
Published in Soft Secreta España 2019 nº04.
Memo: Changes in the scope of international control of medical Cannabis and cannabinoids
Memo for State Parties: Changes in the scope of international control of medical Cannabis and cannabinoids. 4th inter-sessional meeting, 62nd Commission on Narcotic Drugs, June 24th, 2019. DOI: 10.13140/RG.2.2.26406.78409
Livre blanc. Cannabis thérapeutique en France: Quelle régulation pour les patients ?
DOI: 10.13140/RG.2.2.29834.31682/1
Cannabis & Sustainable Development
Paving the way for the next decade in Cannabis and hemp policies.
Alignement des politiques mondiales en matière de drogues avec les objectifs de développement durable de l’agenda 2030
(Collectif) Recommandation de la plateforme interassociative française sur les drogues.
The Crimson Digest, Volume 1
Briefing on the international scientific assessment of cannabis: Processes, stakeholders and history.
ECDD40 Procedural, methodological and terminological bias.
Joint civil society contribution to the 40th meeting of the World Health Organization's Expert Committee on Drug Dependence
Application du Droit à un Recours et à Réparation des Victimes de violations flagrantes du droit international des Droits Humains pour les personnes concernées par la Prohibition
58 ans de violations générales et systématique des Droits Humains au nom du « contrôle des drogues ». Traduction de la Contribution au rapport du Haut Commissaire aux Droits Humains des Nations Unites, en application de la resolution CDH 37/42.
Application of the Right to a Remedy and Reparation for Victims of gross violations of International Human Rights Law in the case of people affected by Prohibition
58 years of global & systematic Human Rights violations in the name of drug control. Re-edition of the Contribution to the United Nations High Commissioner for Human Rights's report pursuant to resolution HRC 37/42.
Joint EIHA – FAAAT contribution to the 39th ECDD evaluation of Cannabidiol
Questionnaire à la société civile, relatif à l’application de la procédure de l’amende forfaitaire au délit d’usage illicite de stupéfiants.
Spanish Doctor Launches Cannabis Research Hub Amid Push for Reform
Published in Leafly News, USA.
La marijuana en la agenda de la OMS
Published in Cañamo Magazine, Spain.
Amid Drug-War Chaos, France is Reconsidering Its Cannabis Policies
Published in Leafly News, USA.
Note de synthèse. Réguler le taux de THC ? Le piège à éviter.
Quid de l’impact et des conséquences d’une limitation du taux de THC (delta-9-TétraHydroCannabinol) en cas de régulation de la filière Cannabis ?
Like Barcelona, Bilbao is Taking Steps to Regulate Cannabis Social Clubs
Published in Leafly News, USA.
How Will Spain’s Local Elections Impact Cannabis Reform?
Published in Leafly News, USA.
Will France Be Stuck with Cannabis Prohibition…Forever?
Published in Leafly News, USA.
Spanish Group Forms to Strengthen Women’s Voice in Cannabis Industry
Published in Leafly News, USA.
TALKS & LECTURES
ASTM D37 Global Workshop on Cannabis/Hemp Standardization
ONLINE
9 Novembre 2020
Derecho internacional del cannabis medicinal para uso veterinario
International Association for Cannabinoid Medicines 20th Anniversary Special Event
5 Novembre 2020
Cannabis medicines & the W.H.O
ASTM D37 Global Workshop on Cannabis/Hemp Standardization
ONLINE
22 Octobre 2020
Fit-for-Purpose Approach & Terminology for Cannabis/Hemp.
III Congrés CannabMed
Col·legi Oficial de Farmacèutics de Barcelona
6-7 Octobre 2020
Cap a una farmacopea cannàbica / Hacia una farmacopea cannábica
State of Cannabis
ONLINE
1 Octobre 2020
Upcoming Cannabis vote inside United Nations – What you need to know
Cannamerica
ONLINE
22 August 2020
Cannabis, Políticas Públicas Sostenibles, y la experiencia de Uruguay.
Hemp Barons w/ Joy Beckerman
ONLINE
August 2020 (Series)
MOMENTUM IN INTERNATIONAL Cannabis POLICY
European Policy Platform
ONLINE
6 August 2020
Cannabis Policy Reforms: European Progress
Radio Free Cannabis w/ Steve DeAngelo
ONLINE
26 JUly 2020
Radio Free Cannabis #8 – Cannabis & Sustainable Development
Prohibition Partners Live
ONLINE
22 JUNE 2020
Overcoming the UN Deadlock
EUROPEAN INDUSTRIAL HEMP ASSOCIATION 17tH CONFERENCE
COLOGNE, GERMANY
17 JUNE 2020
‘Hemp’ products: (p)review of terms and nomenclatures
CannaTalks
ONLINE
10 may 2020
Cáñamo y Desarrollo Sostanible
Cultiva HanfKongress
Pyramid, Vienna, Austria
11 October 2019
MOMENTUM IN INTERNATIONAL Cannabis POLICY
ParLiament Day on Hemp policies
SEIMAS, VILNIUS, LITHUANIA
9 OCTOBER 2019
Statement to the PARLIAMENT OF THE REPUBLIC OF LITHUANIA
EUROPEAN INDUSTRIAL HEMP ASSOCIATION 16TH CONFERENCE
COLOGNE, GERMANY
6 JUNE 2019
Approaching Hemp and Cannabis Policies Through the Lens of Sustainable Development (w/ Hana Gabrielová)
62nd Commission on Narcotic Drugs
United Nations, Vienna, Austria
14 March 2019
Statement to the plenary on item 9(c): International Narcotics Control Board
International Cannabis Policy Conference, Special UN event
United Nations, Vienna, Austria
7 December 2018
Cannabis: Next steps for the Commission on Narcotic Drugs.
II Fòrum de Associacions i Clubs de Cànnabis de Catalunya
Universitat Autònoma de Barcelona, Bellaterra, Spain
23 November 2018
Actualitat social, política i legal del fenomen dels CSC: De la política internacional a la realitat catalana
Open Session of the 41st meeting of the Expert Committee on Drug Dependence
World Health Organization, Geneva, Switzerland
12 November 2018
Statement to the Experts of THE 41 ST MEETING OF THE ECDD
Cultiva HanfKongress
Pyramid, Vienna, Austria
12 October 2018
Cannabis within the UN treaties: are changes finally coming?
Cannabis Box Forum
Expogrow, Irún, Spain
15 September 2018
REGULACIÓN del CANNABIS al INTERNACIONAL
It’s about the future in patient care – how Cannabis will change medical care
Columbia University Global Center, PARIS, FRANCE
12 SEPTEMBER 2018
Access issues: rights, policy & regulation
EUROPEAN INDUSTRIAL HEMP ASSOCIATION 15TH CONFERENCE
COLOGNE, GERMANY
13 JUNE 2018
Cannabidiol and Cannabis Related Substances: a Brief Update on WHO/UN Review Process
Société Civile et Politiques Cannabis, Drug Policy Encounters
Geneva, Switzerland
9 June 2018
Pieces of history and pathways for the future of Cannabis scheduling internationally
European Youth Event 2018
European Parliament, Strasbourg, FRANCE
2 June 2018
Debate. Marijuana: Smells like teen spirit – or escape from reality?
II Congrés CannabMed
CCCB, Barcelona, Spain
13 May 2018
UN PUENTE ENTRE LA MEDICINA CANNÁBICA Y LOS PACIENTES: Perspectiva Internacional
International symposium on prospects for development and growth in the rural cannabis cultivating areas of the Moroccan central Riff
Mohammed VI center, Chefchaouen, Morocco
30 April 2017
Normalisation du Cannabis: l’instrument indispensable pour des politiques de développement socio-économiques inclusives et durables
“Drugs don’t deserve drug policy. To tackle and mitigate drug-related harms, we rather need healthcare, poverty, social, educational, agricultural, geopolitical, security and development policies – that are sensible, and integrate drug-related factors. But we do not need a drug-centred sui generis policy.”